Binance Coin (BNB) is showing signs of stabilization after a sharp breakdown, with price now reacting directly from a key structural support line visible on theBinance Coin (BNB) is showing signs of stabilization after a sharp breakdown, with price now reacting directly from a key structural support line visible on the

BNB Tests Major Support as Reversal Setup Builds

2026/02/25 00:57
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Binance Coin (BNB) is showing signs of stabilization after a sharp breakdown, with price now reacting directly from a key structural support line visible on the higher-timeframe chart shared by GainMuse.

The recent plunge appears to resemble a liquidity sweep rather than sustained continuation, as price begins compressing inside a tightening formation.

The broader structure shows BNB previously breaking down from a large distribution range before accelerating into a steep selloff. However, price has now tapped the lower boundary of the macro support channel, a level that has historically acted as a reaction zone.

Support Reaction Holding for Now

BNB is currently trading near the $585–$600 region after the aggressive February drop. The move wiped out a large portion of the prior advance, with price cascading from above $900 toward the $600 zone in a matter of days.

The key observation is that sellers failed to extend the breakdown immediately after tapping structural support. Instead, price has begun consolidating within a small triangle near the lows, signaling potential absorption.

If this level continues to hold, the first logical upside objective would be a recovery toward the descending resistance trendline visible on the GainMuse chart. That area aligns roughly with the mid-$600s to low-$700s region, depending on momentum.

Meta Plans Stablecoin Comeback After Diem Collapse

Liquidity Sweep or Continuation?

GainMuse frames the drop as a likely liquidity event rather than the start of a fresh impulsive leg lower. The idea is that price swept below recent structure, triggered stops, and immediately stabilized at macro support.

This scenario strengthens if BNB maintains higher lows inside the current compression range and begins reclaiming short-term resistance levels.

However, the bullish rotation thesis remains conditional.

A clean breakdown below the recent swing low would invalidate the reversal narrative and open the door for continuation toward deeper support zones within the broader channel.

What to Watch Next

The immediate battle is centered around structural support. As long as BNB holds above this macro trendline and continues compressing rather than impulsively selling, the probability of a relief move increases.

Failure to defend this zone, especially on higher-timeframe closes, would shift momentum decisively back in favor of sellers.

For now, the chart suggests BNB is attempting to build a base after a violent correction. Whether this develops into a meaningful reversal or another leg down will depend entirely on how price behaves around this key support cluster in the coming sessions.

The post BNB Tests Major Support as Reversal Setup Builds appeared first on ETHNews.

Market Opportunity
Binance Coin Logo
Binance Coin Price(BNB)
$629.89
$629.89$629.89
+0.30%
USD
Binance Coin (BNB) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09